Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
20,707
archived clinical trials in
Gastrointestinal

Evaluation of Computer-assisted, Non-cathartic CT Colonography
Prospective Evaluation of Computer-Assisted, Non-Cathartic CT Colonography for Detection of Adenomatous Colonic Polyps in a Screening Cohort
Status: Enrolling
Updated:  8/3/2015
Massachusetts General Hospital
mi
from
Boston, MA
Evaluation of Computer-assisted, Non-cathartic CT Colonography
Prospective Evaluation of Computer-Assisted, Non-Cathartic CT Colonography for Detection of Adenomatous Colonic Polyps in a Screening Cohort
Status: Enrolling
Updated: 8/3/2015
Massachusetts General Hospital
mi
from
Boston, MA
Click here to add this to my saved trials
Evaluation of Computer-assisted, Non-cathartic CT Colonography
Prospective Evaluation of Computer-Assisted, Non-Cathartic CT Colonography for Detection of Adenomatous Colonic Polyps in a Screening Cohort
Status: Enrolling
Updated:  8/3/2015
Brigham and Women's Hosp
mi
from
Boston, MA
Evaluation of Computer-assisted, Non-cathartic CT Colonography
Prospective Evaluation of Computer-Assisted, Non-Cathartic CT Colonography for Detection of Adenomatous Colonic Polyps in a Screening Cohort
Status: Enrolling
Updated: 8/3/2015
Brigham and Women's Hosp
mi
from
Boston, MA
Click here to add this to my saved trials
Models of Screening, Brief Intervention With a Facilitated Referral to Treatment (SBIRT) for Opioid Patients in the Emergency Department
Models of Screening, Brief Intervention With a Facilitated Referral to Treatment (SBIRT) for Opioid Patients in the Emergency Department
Status: Enrolling
Updated:  8/4/2015
Yale University
mi
from
New Haven, CT
Models of Screening, Brief Intervention With a Facilitated Referral to Treatment (SBIRT) for Opioid Patients in the Emergency Department
Models of Screening, Brief Intervention With a Facilitated Referral to Treatment (SBIRT) for Opioid Patients in the Emergency Department
Status: Enrolling
Updated: 8/4/2015
Yale University
mi
from
New Haven, CT
Click here to add this to my saved trials
Models of Screening, Brief Intervention With a Facilitated Referral to Treatment (SBIRT) for Opioid Patients in the Emergency Department
Models of Screening, Brief Intervention With a Facilitated Referral to Treatment (SBIRT) for Opioid Patients in the Emergency Department
Status: Enrolling
Updated:  8/4/2015
Yale University School of Medicine
mi
from
New Haven, CT
Models of Screening, Brief Intervention With a Facilitated Referral to Treatment (SBIRT) for Opioid Patients in the Emergency Department
Models of Screening, Brief Intervention With a Facilitated Referral to Treatment (SBIRT) for Opioid Patients in the Emergency Department
Status: Enrolling
Updated: 8/4/2015
Yale University School of Medicine
mi
from
New Haven, CT
Click here to add this to my saved trials
Pilot/Ph I Safety and Efficacy of ODSH in Protein Losing Enteropathy Secondary to Single Ventricle Palliative Surgery
" An Open Label Pilot Study Evaluating Safety and Evidence of Therapeutic Effect of IV Admin of 2-0, 3-0 Desulfated Heparin, Treatment of Exacerbation of Protein Losing Enteropathy (PLE) Associated With Single Ventricle Palliative Surgery"
Status: Enrolling
Updated:  8/5/2015
Children's Hospital Los Angeles ( Gastroenterology & Nutrition)
mi
from
Los Angeles, CA
Pilot/Ph I Safety and Efficacy of ODSH in Protein Losing Enteropathy Secondary to Single Ventricle Palliative Surgery
" An Open Label Pilot Study Evaluating Safety and Evidence of Therapeutic Effect of IV Admin of 2-0, 3-0 Desulfated Heparin, Treatment of Exacerbation of Protein Losing Enteropathy (PLE) Associated With Single Ventricle Palliative Surgery"
Status: Enrolling
Updated: 8/5/2015
Children's Hospital Los Angeles ( Gastroenterology & Nutrition)
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Pilot/Ph I Safety and Efficacy of ODSH in Protein Losing Enteropathy Secondary to Single Ventricle Palliative Surgery
" An Open Label Pilot Study Evaluating Safety and Evidence of Therapeutic Effect of IV Admin of 2-0, 3-0 Desulfated Heparin, Treatment of Exacerbation of Protein Losing Enteropathy (PLE) Associated With Single Ventricle Palliative Surgery"
Status: Enrolling
Updated:  8/5/2015
Sanford Children's ( Sanford Research / USD)
mi
from
Sioux Falls, SD
Pilot/Ph I Safety and Efficacy of ODSH in Protein Losing Enteropathy Secondary to Single Ventricle Palliative Surgery
" An Open Label Pilot Study Evaluating Safety and Evidence of Therapeutic Effect of IV Admin of 2-0, 3-0 Desulfated Heparin, Treatment of Exacerbation of Protein Losing Enteropathy (PLE) Associated With Single Ventricle Palliative Surgery"
Status: Enrolling
Updated: 8/5/2015
Sanford Children's ( Sanford Research / USD)
mi
from
Sioux Falls, SD
Click here to add this to my saved trials
Pilot/Ph I Safety and Efficacy of ODSH in Protein Losing Enteropathy Secondary to Single Ventricle Palliative Surgery
" An Open Label Pilot Study Evaluating Safety and Evidence of Therapeutic Effect of IV Admin of 2-0, 3-0 Desulfated Heparin, Treatment of Exacerbation of Protein Losing Enteropathy (PLE) Associated With Single Ventricle Palliative Surgery"
Status: Enrolling
Updated:  8/5/2015
Department of Cardiology, Children's Hospital Boston
mi
from
Boston, MA
Pilot/Ph I Safety and Efficacy of ODSH in Protein Losing Enteropathy Secondary to Single Ventricle Palliative Surgery
" An Open Label Pilot Study Evaluating Safety and Evidence of Therapeutic Effect of IV Admin of 2-0, 3-0 Desulfated Heparin, Treatment of Exacerbation of Protein Losing Enteropathy (PLE) Associated With Single Ventricle Palliative Surgery"
Status: Enrolling
Updated: 8/5/2015
Department of Cardiology, Children's Hospital Boston
mi
from
Boston, MA
Click here to add this to my saved trials
Pilot/Ph I Safety and Efficacy of ODSH in Protein Losing Enteropathy Secondary to Single Ventricle Palliative Surgery
" An Open Label Pilot Study Evaluating Safety and Evidence of Therapeutic Effect of IV Admin of 2-0, 3-0 Desulfated Heparin, Treatment of Exacerbation of Protein Losing Enteropathy (PLE) Associated With Single Ventricle Palliative Surgery"
Status: Enrolling
Updated:  8/5/2015
Division of Pediatric Cardiology, University of Michigan Health System
mi
from
Ann Arbor, MI
Pilot/Ph I Safety and Efficacy of ODSH in Protein Losing Enteropathy Secondary to Single Ventricle Palliative Surgery
" An Open Label Pilot Study Evaluating Safety and Evidence of Therapeutic Effect of IV Admin of 2-0, 3-0 Desulfated Heparin, Treatment of Exacerbation of Protein Losing Enteropathy (PLE) Associated With Single Ventricle Palliative Surgery"
Status: Enrolling
Updated: 8/5/2015
Division of Pediatric Cardiology, University of Michigan Health System
mi
from
Ann Arbor, MI
Click here to add this to my saved trials
Mitochondria Inborn Errors of Metabolism and ANT Defects in Mitochondria Diseases
Investigation of the Nature and Prevalence of Mitochondria Disease
Status: Enrolling
Updated:  8/5/2015
Beckman Laser Institute Medical clinic
mi
from
Irvine, CA
Mitochondria Inborn Errors of Metabolism and ANT Defects in Mitochondria Diseases
Investigation of the Nature and Prevalence of Mitochondria Disease
Status: Enrolling
Updated: 8/5/2015
Beckman Laser Institute Medical clinic
mi
from
Irvine, CA
Click here to add this to my saved trials
Neurobiology of Opioid Dependence: 1 - 1
Neurobiology of Opioid Dependence: 1
Status: Enrolling
Updated:  8/5/2015
VA Connecticut HealthCare System
mi
from
New Haven, CT
Neurobiology of Opioid Dependence: 1 - 1
Neurobiology of Opioid Dependence: 1
Status: Enrolling
Updated: 8/5/2015
VA Connecticut HealthCare System
mi
from
New Haven, CT
Click here to add this to my saved trials
Neurobiology of Opioid Dependence: 2 - 2
Neurobiology of Opioid Dependence: 2
Status: Enrolling
Updated:  8/5/2015
VA Connecticut HealthCare System
mi
from
New Haven, CT
Neurobiology of Opioid Dependence: 2 - 2
Neurobiology of Opioid Dependence: 2
Status: Enrolling
Updated: 8/5/2015
VA Connecticut HealthCare System
mi
from
New Haven, CT
Click here to add this to my saved trials
A Randomized, 4-sequence, 2-period, Double-blind, Placebo Controlled Study With a DSM-IV-TR Diagnosis of Cocaine Abuse
A Randomized, Double-blind, Placebo-controlled, Dose of RBP-8000 Following IV Cocaine to Evaluate the Pharmacokinetics Parameters of RBP-8000 and Cocaine and to Assess the Effects of Drug on Cocaine-induced Physiologic and Behavioral Effects in Cocaine Abusing Subjects
Status: Enrolling
Updated:  8/5/2015
Vince and Associates Clinical Research
mi
from
Overland Park, KA
A Randomized, 4-sequence, 2-period, Double-blind, Placebo Controlled Study With a DSM-IV-TR Diagnosis of Cocaine Abuse
A Randomized, Double-blind, Placebo-controlled, Dose of RBP-8000 Following IV Cocaine to Evaluate the Pharmacokinetics Parameters of RBP-8000 and Cocaine and to Assess the Effects of Drug on Cocaine-induced Physiologic and Behavioral Effects in Cocaine Abusing Subjects
Status: Enrolling
Updated: 8/5/2015
Vince and Associates Clinical Research
mi
from
Overland Park, KA
Click here to add this to my saved trials
Fluorescent Evaluation of Colorectal Anastamoses
The Use of Fluorescent Imaging to Evaluate Bowel Anastomotic Perfusion
Status: Enrolling
Updated:  8/6/2015
Maimonides Medical Center
mi
from
Brooklyn, NY
Fluorescent Evaluation of Colorectal Anastamoses
The Use of Fluorescent Imaging to Evaluate Bowel Anastomotic Perfusion
Status: Enrolling
Updated: 8/6/2015
Maimonides Medical Center
mi
from
Brooklyn, NY
Click here to add this to my saved trials
Myfortic in High MELD Liver Transplantation
Prospective Evaluation of the Efficacy and Safety of Zortress (Everolimus)/Myfortic (Enteric Coated Mycophenolate Sodium) Conversion in High MELD Liver Transplantation
Status: Enrolling
Updated:  8/7/2015
University of Colorado Denver
mi
from
Aurora, CO
Myfortic in High MELD Liver Transplantation
Prospective Evaluation of the Efficacy and Safety of Zortress (Everolimus)/Myfortic (Enteric Coated Mycophenolate Sodium) Conversion in High MELD Liver Transplantation
Status: Enrolling
Updated: 8/7/2015
University of Colorado Denver
mi
from
Aurora, CO
Click here to add this to my saved trials
Can CT Enteroclysis Predict the Outcome of Crohn's Disease
Can CT Enteroclysis Predict the Response to Therapy and Outcome in Patient With Crohn's Disease
Status: Enrolling
Updated:  8/7/2015
Indiana University
mi
from
Indianapolis, IN
Can CT Enteroclysis Predict the Outcome of Crohn's Disease
Can CT Enteroclysis Predict the Response to Therapy and Outcome in Patient With Crohn's Disease
Status: Enrolling
Updated: 8/7/2015
Indiana University
mi
from
Indianapolis, IN
Click here to add this to my saved trials
Prevalence of Lymphoma in IBD
Prevalence and Risk Factor for Lymphoproliferative Disease in Patients With Inflammatory Bowel Disease
Status: Enrolling
Updated:  8/7/2015
Indiana University Medical Center
mi
from
Indianapolis, IN
Prevalence of Lymphoma in IBD
Prevalence and Risk Factor for Lymphoproliferative Disease in Patients With Inflammatory Bowel Disease
Status: Enrolling
Updated: 8/7/2015
Indiana University Medical Center
mi
from
Indianapolis, IN
Click here to add this to my saved trials
Value of Fecal Calprotectin
Correlation of Fecal Calprotectin Level With the Clinical, Endoscopic, Histologic and Radiologic Activity in Inflammatory Bowel diseaseThe Value of Fecal Calprotectin for the Diagnosis and Assessment of Inflammatory Bowel Disease
Status: Enrolling
Updated:  8/7/2015
Indiana University
mi
from
Indianapolis, IN
Value of Fecal Calprotectin
Correlation of Fecal Calprotectin Level With the Clinical, Endoscopic, Histologic and Radiologic Activity in Inflammatory Bowel diseaseThe Value of Fecal Calprotectin for the Diagnosis and Assessment of Inflammatory Bowel Disease
Status: Enrolling
Updated: 8/7/2015
Indiana University
mi
from
Indianapolis, IN
Click here to add this to my saved trials
Determination of the Pathophysicologic Collagen Changes in the Diabetic Achilles Tendon
Determination of the Pathophysicologic Collagen Changes in the Diabetic Achilles Tendon.
Status: Enrolling
Updated:  8/10/2015
Georgetown University Hospital Center for Wound Healing
mi
from
Washington,
Determination of the Pathophysicologic Collagen Changes in the Diabetic Achilles Tendon
Determination of the Pathophysicologic Collagen Changes in the Diabetic Achilles Tendon.
Status: Enrolling
Updated: 8/10/2015
Georgetown University Hospital Center for Wound Healing
mi
from
Washington,
Click here to add this to my saved trials
Gastrointestinal Myoelectric Activity Protocol, the G-Tech EEnG Protocol
A Feasibility Study For Monitoring And Recording Gastrointestinal Myoelectric Activity In Subjects With Suspected Or Diagnosed Irritable Bowel Syndrome (Lbs) And Reports Of GI Pain And Asymptomatic Subjects Without Lbs And GI Pain
Status: Enrolling
Updated:  8/11/2015
G-Tech Corporation
mi
from
Mountain View, CA
Gastrointestinal Myoelectric Activity Protocol, the G-Tech EEnG Protocol
A Feasibility Study For Monitoring And Recording Gastrointestinal Myoelectric Activity In Subjects With Suspected Or Diagnosed Irritable Bowel Syndrome (Lbs) And Reports Of GI Pain And Asymptomatic Subjects Without Lbs And GI Pain
Status: Enrolling
Updated: 8/11/2015
G-Tech Corporation
mi
from
Mountain View, CA
Click here to add this to my saved trials
A Comparison of Three Fluoroquinolone Topical Eyedrops in the Treatment of Infectious Corneal Ulcers.
A Single-site, Single Masked, Prospective Comparison of Three Fluoroquinolone Topical Therapies (Besifloxacin 0.6% or Gatifloxacin 0.5% or Moxifloxacin 0.5%) in the Treatment of Infectious Corneal Ulcers.
Status: Enrolling
Updated:  8/11/2015
Cornea Consultants of Nashville
mi
from
Nashville, TN
A Comparison of Three Fluoroquinolone Topical Eyedrops in the Treatment of Infectious Corneal Ulcers.
A Single-site, Single Masked, Prospective Comparison of Three Fluoroquinolone Topical Therapies (Besifloxacin 0.6% or Gatifloxacin 0.5% or Moxifloxacin 0.5%) in the Treatment of Infectious Corneal Ulcers.
Status: Enrolling
Updated: 8/11/2015
Cornea Consultants of Nashville
mi
from
Nashville, TN
Click here to add this to my saved trials
Fast Track Appendectomy for Suppurative Appendicitis
Fast Track Appendectomy in Pediatric Patients With Intraoperative Findings of Suppurative Appendicitis
Status: Enrolling
Updated:  8/12/2015
All Children's Hospital Johns Hopkins Medicine
mi
from
Saint Petersburg, FL
Fast Track Appendectomy for Suppurative Appendicitis
Fast Track Appendectomy in Pediatric Patients With Intraoperative Findings of Suppurative Appendicitis
Status: Enrolling
Updated: 8/12/2015
All Children's Hospital Johns Hopkins Medicine
mi
from
Saint Petersburg, FL
Click here to add this to my saved trials
Treatment of Patients With Fecal Incontinence
Biofeedback Therapy for Fecal Incontinence a Randomized Control Trial
Status: Enrolling
Updated:  8/13/2015
VA Greater Los Angeles Healthcare System, Sepulveda, CA
mi
from
Sepulveda, CA
Treatment of Patients With Fecal Incontinence
Biofeedback Therapy for Fecal Incontinence a Randomized Control Trial
Status: Enrolling
Updated: 8/13/2015
VA Greater Los Angeles Healthcare System, Sepulveda, CA
mi
from
Sepulveda, CA
Click here to add this to my saved trials
Comparative Study of Amniotic Membrane Wound Graft In the Management of Diabetic Foot Ulcers
A Prospective, Randomized, Comparative Parallel Study of Amniotic Membrane Wound Graft In the Management of Diabetic Foot Ulcers
Status: Enrolling
Updated:  8/13/2015
Professional Education and Research Institute
mi
from
Roanoke, VA
Comparative Study of Amniotic Membrane Wound Graft In the Management of Diabetic Foot Ulcers
A Prospective, Randomized, Comparative Parallel Study of Amniotic Membrane Wound Graft In the Management of Diabetic Foot Ulcers
Status: Enrolling
Updated: 8/13/2015
Professional Education and Research Institute
mi
from
Roanoke, VA
Click here to add this to my saved trials
IBD-OPERA Database, UC Protocol
IBD-OPERA Database: Inflammatory Bowel Disease - Outcomes, Preferences, Education, Resource Utilization, Assessment Database
Status: Enrolling
Updated:  8/14/2015
Dartmouth Hitchcock Medical Center
mi
from
Lebanon, NH
IBD-OPERA Database, UC Protocol
IBD-OPERA Database: Inflammatory Bowel Disease - Outcomes, Preferences, Education, Resource Utilization, Assessment Database
Status: Enrolling
Updated: 8/14/2015
Dartmouth Hitchcock Medical Center
mi
from
Lebanon, NH
Click here to add this to my saved trials
OPERA Database - Crohn's Protocol
IBD-OPERA Database IBD OPERA Database: Inflammatory Bowel Disease - Outcomes, Preferences, Education, Resource Utilization, Assessment Database - Crohn's Protocol
Status: Enrolling
Updated:  8/14/2015
Dartmouth Hitchcock Medical Center
mi
from
Lebanon, NH
OPERA Database - Crohn's Protocol
IBD-OPERA Database IBD OPERA Database: Inflammatory Bowel Disease - Outcomes, Preferences, Education, Resource Utilization, Assessment Database - Crohn's Protocol
Status: Enrolling
Updated: 8/14/2015
Dartmouth Hitchcock Medical Center
mi
from
Lebanon, NH
Click here to add this to my saved trials
Pharmacokinetics of LCP-Tacro in Stable Liver Transplant Patients
A Phase II, Open-Label, Multi-Center Prospective, Conversion Study in Stable Liver Transplant Patients to Compare the Pharmacokinetics of LCP-Tacro Tablets Once-A-Day to Prograf® Capsules Twice-A-Day
Status: Enrolling
Updated:  8/14/2015
University of Cincinnati
mi
from
Cincinnati, OH
Pharmacokinetics of LCP-Tacro in Stable Liver Transplant Patients
A Phase II, Open-Label, Multi-Center Prospective, Conversion Study in Stable Liver Transplant Patients to Compare the Pharmacokinetics of LCP-Tacro Tablets Once-A-Day to Prograf® Capsules Twice-A-Day
Status: Enrolling
Updated: 8/14/2015
University of Cincinnati
mi
from
Cincinnati, OH
Click here to add this to my saved trials
A Comparison of Two Albumin Administration Schedules for Spontaneous Bacterial Peritonitis
A Randomized Comparison of Two Albumin Administration Schedules for Spontaneous Bacterial Peritonitis
Status: Enrolling
Updated:  8/18/2015
NYU Langone Medical Center
mi
from
New York, NY
A Comparison of Two Albumin Administration Schedules for Spontaneous Bacterial Peritonitis
A Randomized Comparison of Two Albumin Administration Schedules for Spontaneous Bacterial Peritonitis
Status: Enrolling
Updated: 8/18/2015
NYU Langone Medical Center
mi
from
New York, NY
Click here to add this to my saved trials
Hybrid Transvaginal-Transabdominal Endoscopic Surgery
Hybrid Transvaginal-Transabdominal Endoscopic Surgery
Status: Enrolling
Updated:  8/19/2015
St Luke's - Roosevelt Hospital Center
mi
from
New York, NY
Hybrid Transvaginal-Transabdominal Endoscopic Surgery
Hybrid Transvaginal-Transabdominal Endoscopic Surgery
Status: Enrolling
Updated: 8/19/2015
St Luke's - Roosevelt Hospital Center
mi
from
New York, NY
Click here to add this to my saved trials
ERADICATE Hp - Treating Helicobacter Pylori With RHB-105
A Randomized Placebo-Controlled Phase 3 Study to Assess the Safety and Efficacy of RHB-105 in the Treatment of Confirmed Helicobacter Pylori (H. Pylori) Infection in Non-investigated Dyspepsia Patients
Status: Enrolling
Updated:  8/19/2015
Anaheim Clinical Trials, LLC
mi
from
Anaheim, CA
ERADICATE Hp - Treating Helicobacter Pylori With RHB-105
A Randomized Placebo-Controlled Phase 3 Study to Assess the Safety and Efficacy of RHB-105 in the Treatment of Confirmed Helicobacter Pylori (H. Pylori) Infection in Non-investigated Dyspepsia Patients
Status: Enrolling
Updated: 8/19/2015
Anaheim Clinical Trials, LLC
mi
from
Anaheim, CA
Click here to add this to my saved trials
ERADICATE Hp - Treating Helicobacter Pylori With RHB-105
A Randomized Placebo-Controlled Phase 3 Study to Assess the Safety and Efficacy of RHB-105 in the Treatment of Confirmed Helicobacter Pylori (H. Pylori) Infection in Non-investigated Dyspepsia Patients
Status: Enrolling
Updated:  8/19/2015
Anaheim Clinical Trials, LLC
mi
from
Anaheim, CA
ERADICATE Hp - Treating Helicobacter Pylori With RHB-105
A Randomized Placebo-Controlled Phase 3 Study to Assess the Safety and Efficacy of RHB-105 in the Treatment of Confirmed Helicobacter Pylori (H. Pylori) Infection in Non-investigated Dyspepsia Patients
Status: Enrolling
Updated: 8/19/2015
Anaheim Clinical Trials, LLC
mi
from
Anaheim, CA
Click here to add this to my saved trials
ERADICATE Hp - Treating Helicobacter Pylori With RHB-105
A Randomized Placebo-Controlled Phase 3 Study to Assess the Safety and Efficacy of RHB-105 in the Treatment of Confirmed Helicobacter Pylori (H. Pylori) Infection in Non-investigated Dyspepsia Patients
Status: Enrolling
Updated:  8/19/2015
Catalina Research Institute
mi
from
Chino, CA
ERADICATE Hp - Treating Helicobacter Pylori With RHB-105
A Randomized Placebo-Controlled Phase 3 Study to Assess the Safety and Efficacy of RHB-105 in the Treatment of Confirmed Helicobacter Pylori (H. Pylori) Infection in Non-investigated Dyspepsia Patients
Status: Enrolling
Updated: 8/19/2015
Catalina Research Institute
mi
from
Chino, CA
Click here to add this to my saved trials
ERADICATE Hp - Treating Helicobacter Pylori With RHB-105
A Randomized Placebo-Controlled Phase 3 Study to Assess the Safety and Efficacy of RHB-105 in the Treatment of Confirmed Helicobacter Pylori (H. Pylori) Infection in Non-investigated Dyspepsia Patients
Status: Enrolling
Updated:  8/19/2015
Jupiter Research
mi
from
Jupiter, FL
ERADICATE Hp - Treating Helicobacter Pylori With RHB-105
A Randomized Placebo-Controlled Phase 3 Study to Assess the Safety and Efficacy of RHB-105 in the Treatment of Confirmed Helicobacter Pylori (H. Pylori) Infection in Non-investigated Dyspepsia Patients
Status: Enrolling
Updated: 8/19/2015
Jupiter Research
mi
from
Jupiter, FL
Click here to add this to my saved trials
ERADICATE Hp - Treating Helicobacter Pylori With RHB-105
A Randomized Placebo-Controlled Phase 3 Study to Assess the Safety and Efficacy of RHB-105 in the Treatment of Confirmed Helicobacter Pylori (H. Pylori) Infection in Non-investigated Dyspepsia Patients
Status: Enrolling
Updated:  8/19/2015
Columbus Regional Research Institute
mi
from
Columbus, GA
ERADICATE Hp - Treating Helicobacter Pylori With RHB-105
A Randomized Placebo-Controlled Phase 3 Study to Assess the Safety and Efficacy of RHB-105 in the Treatment of Confirmed Helicobacter Pylori (H. Pylori) Infection in Non-investigated Dyspepsia Patients
Status: Enrolling
Updated: 8/19/2015
Columbus Regional Research Institute
mi
from
Columbus, GA
Click here to add this to my saved trials
ERADICATE Hp - Treating Helicobacter Pylori With RHB-105
A Randomized Placebo-Controlled Phase 3 Study to Assess the Safety and Efficacy of RHB-105 in the Treatment of Confirmed Helicobacter Pylori (H. Pylori) Infection in Non-investigated Dyspepsia Patients
Status: Enrolling
Updated:  8/19/2015
MedPharmics, LLC.
mi
from
Metairie, LA
ERADICATE Hp - Treating Helicobacter Pylori With RHB-105
A Randomized Placebo-Controlled Phase 3 Study to Assess the Safety and Efficacy of RHB-105 in the Treatment of Confirmed Helicobacter Pylori (H. Pylori) Infection in Non-investigated Dyspepsia Patients
Status: Enrolling
Updated: 8/19/2015
MedPharmics, LLC.
mi
from
Metairie, LA
Click here to add this to my saved trials
ERADICATE Hp - Treating Helicobacter Pylori With RHB-105
A Randomized Placebo-Controlled Phase 3 Study to Assess the Safety and Efficacy of RHB-105 in the Treatment of Confirmed Helicobacter Pylori (H. Pylori) Infection in Non-investigated Dyspepsia Patients
Status: Enrolling
Updated:  8/19/2015
Investigative Clinical Research
mi
from
Annapolis, MD
ERADICATE Hp - Treating Helicobacter Pylori With RHB-105
A Randomized Placebo-Controlled Phase 3 Study to Assess the Safety and Efficacy of RHB-105 in the Treatment of Confirmed Helicobacter Pylori (H. Pylori) Infection in Non-investigated Dyspepsia Patients
Status: Enrolling
Updated: 8/19/2015
Investigative Clinical Research
mi
from
Annapolis, MD
Click here to add this to my saved trials
ERADICATE Hp - Treating Helicobacter Pylori With RHB-105
A Randomized Placebo-Controlled Phase 3 Study to Assess the Safety and Efficacy of RHB-105 in the Treatment of Confirmed Helicobacter Pylori (H. Pylori) Infection in Non-investigated Dyspepsia Patients
Status: Enrolling
Updated:  8/19/2015
MGG Group, Co. Inc./Chevy Chase Clinical Research
mi
from
Chevy Chase, MD
ERADICATE Hp - Treating Helicobacter Pylori With RHB-105
A Randomized Placebo-Controlled Phase 3 Study to Assess the Safety and Efficacy of RHB-105 in the Treatment of Confirmed Helicobacter Pylori (H. Pylori) Infection in Non-investigated Dyspepsia Patients
Status: Enrolling
Updated: 8/19/2015
MGG Group, Co. Inc./Chevy Chase Clinical Research
mi
from
Chevy Chase, MD
Click here to add this to my saved trials
ERADICATE Hp - Treating Helicobacter Pylori With RHB-105
A Randomized Placebo-Controlled Phase 3 Study to Assess the Safety and Efficacy of RHB-105 in the Treatment of Confirmed Helicobacter Pylori (H. Pylori) Infection in Non-investigated Dyspepsia Patients
Status: Enrolling
Updated:  8/19/2015
Detroit Clinical Research Center PC
mi
from
Farmington Hills, MI
ERADICATE Hp - Treating Helicobacter Pylori With RHB-105
A Randomized Placebo-Controlled Phase 3 Study to Assess the Safety and Efficacy of RHB-105 in the Treatment of Confirmed Helicobacter Pylori (H. Pylori) Infection in Non-investigated Dyspepsia Patients
Status: Enrolling
Updated: 8/19/2015
Detroit Clinical Research Center PC
mi
from
Farmington Hills, MI
Click here to add this to my saved trials
ERADICATE Hp - Treating Helicobacter Pylori With RHB-105
A Randomized Placebo-Controlled Phase 3 Study to Assess the Safety and Efficacy of RHB-105 in the Treatment of Confirmed Helicobacter Pylori (H. Pylori) Infection in Non-investigated Dyspepsia Patients
Status: Enrolling
Updated:  8/19/2015
Office of Stephen Miller, M.D.
mi
from
Las Vegas, NV
ERADICATE Hp - Treating Helicobacter Pylori With RHB-105
A Randomized Placebo-Controlled Phase 3 Study to Assess the Safety and Efficacy of RHB-105 in the Treatment of Confirmed Helicobacter Pylori (H. Pylori) Infection in Non-investigated Dyspepsia Patients
Status: Enrolling
Updated: 8/19/2015
Office of Stephen Miller, M.D.
mi
from
Las Vegas, NV
Click here to add this to my saved trials
ERADICATE Hp - Treating Helicobacter Pylori With RHB-105
A Randomized Placebo-Controlled Phase 3 Study to Assess the Safety and Efficacy of RHB-105 in the Treatment of Confirmed Helicobacter Pylori (H. Pylori) Infection in Non-investigated Dyspepsia Patients
Status: Enrolling
Updated:  8/19/2015
Peters Medical Research
mi
from
HIgh Point, NC
ERADICATE Hp - Treating Helicobacter Pylori With RHB-105
A Randomized Placebo-Controlled Phase 3 Study to Assess the Safety and Efficacy of RHB-105 in the Treatment of Confirmed Helicobacter Pylori (H. Pylori) Infection in Non-investigated Dyspepsia Patients
Status: Enrolling
Updated: 8/19/2015
Peters Medical Research
mi
from
HIgh Point, NC
Click here to add this to my saved trials
ERADICATE Hp - Treating Helicobacter Pylori With RHB-105
A Randomized Placebo-Controlled Phase 3 Study to Assess the Safety and Efficacy of RHB-105 in the Treatment of Confirmed Helicobacter Pylori (H. Pylori) Infection in Non-investigated Dyspepsia Patients
Status: Enrolling
Updated:  8/19/2015
Wake Research Associates, LLC
mi
from
Raleigh, NC
ERADICATE Hp - Treating Helicobacter Pylori With RHB-105
A Randomized Placebo-Controlled Phase 3 Study to Assess the Safety and Efficacy of RHB-105 in the Treatment of Confirmed Helicobacter Pylori (H. Pylori) Infection in Non-investigated Dyspepsia Patients
Status: Enrolling
Updated: 8/19/2015
Wake Research Associates, LLC
mi
from
Raleigh, NC
Click here to add this to my saved trials
A Study To Evaluate Both The Efficacy and Safety Profile of CP-690,550 In Patients With Moderately to Severely Active Ulcerative Colitis
A Multicentre, Randomized, Double-blind, Placebo-controlled, Parallel-group Study Of Oral Cp-690,550 As An Induction Therapy In Subjects With Moderate To Severe Ulcerative Colitis.
Status: Enrolling
Updated:  8/20/2015
Desert Sun Clinical Research, LCC
mi
from
Tucson, AZ
A Study To Evaluate Both The Efficacy and Safety Profile of CP-690,550 In Patients With Moderately to Severely Active Ulcerative Colitis
A Multicentre, Randomized, Double-blind, Placebo-controlled, Parallel-group Study Of Oral Cp-690,550 As An Induction Therapy In Subjects With Moderate To Severe Ulcerative Colitis.
Status: Enrolling
Updated: 8/20/2015
Desert Sun Clinical Research, LCC
mi
from
Tucson, AZ
Click here to add this to my saved trials
A Study To Evaluate Both The Efficacy and Safety Profile of CP-690,550 In Patients With Moderately to Severely Active Ulcerative Colitis
A Multicentre, Randomized, Double-blind, Placebo-controlled, Parallel-group Study Of Oral Cp-690,550 As An Induction Therapy In Subjects With Moderate To Severe Ulcerative Colitis.
Status: Enrolling
Updated:  8/20/2015
Desert Sun Gastroenterology
mi
from
Tucson, AZ
A Study To Evaluate Both The Efficacy and Safety Profile of CP-690,550 In Patients With Moderately to Severely Active Ulcerative Colitis
A Multicentre, Randomized, Double-blind, Placebo-controlled, Parallel-group Study Of Oral Cp-690,550 As An Induction Therapy In Subjects With Moderate To Severe Ulcerative Colitis.
Status: Enrolling
Updated: 8/20/2015
Desert Sun Gastroenterology
mi
from
Tucson, AZ
Click here to add this to my saved trials
A Study To Evaluate Both The Efficacy and Safety Profile of CP-690,550 In Patients With Moderately to Severely Active Ulcerative Colitis
A Multicentre, Randomized, Double-blind, Placebo-controlled, Parallel-group Study Of Oral Cp-690,550 As An Induction Therapy In Subjects With Moderate To Severe Ulcerative Colitis.
Status: Enrolling
Updated:  8/20/2015
Desert Sun Surgery Center
mi
from
Tucson, AZ
A Study To Evaluate Both The Efficacy and Safety Profile of CP-690,550 In Patients With Moderately to Severely Active Ulcerative Colitis
A Multicentre, Randomized, Double-blind, Placebo-controlled, Parallel-group Study Of Oral Cp-690,550 As An Induction Therapy In Subjects With Moderate To Severe Ulcerative Colitis.
Status: Enrolling
Updated: 8/20/2015
Desert Sun Surgery Center
mi
from
Tucson, AZ
Click here to add this to my saved trials
A Study To Evaluate Both The Efficacy and Safety Profile of CP-690,550 In Patients With Moderately to Severely Active Ulcerative Colitis
A Multicentre, Randomized, Double-blind, Placebo-controlled, Parallel-group Study Of Oral Cp-690,550 As An Induction Therapy In Subjects With Moderate To Severe Ulcerative Colitis.
Status: Enrolling
Updated:  8/20/2015
Alliance Clinical Research
mi
from
Oceanside, CA
A Study To Evaluate Both The Efficacy and Safety Profile of CP-690,550 In Patients With Moderately to Severely Active Ulcerative Colitis
A Multicentre, Randomized, Double-blind, Placebo-controlled, Parallel-group Study Of Oral Cp-690,550 As An Induction Therapy In Subjects With Moderate To Severe Ulcerative Colitis.
Status: Enrolling
Updated: 8/20/2015
Alliance Clinical Research
mi
from
Oceanside, CA
Click here to add this to my saved trials
A Study To Evaluate Both The Efficacy and Safety Profile of CP-690,550 In Patients With Moderately to Severely Active Ulcerative Colitis
A Multicentre, Randomized, Double-blind, Placebo-controlled, Parallel-group Study Of Oral Cp-690,550 As An Induction Therapy In Subjects With Moderate To Severe Ulcerative Colitis.
Status: Enrolling
Updated:  8/20/2015
Clinical Application Laboratories, Inc.
mi
from
San Diego, CA
A Study To Evaluate Both The Efficacy and Safety Profile of CP-690,550 In Patients With Moderately to Severely Active Ulcerative Colitis
A Multicentre, Randomized, Double-blind, Placebo-controlled, Parallel-group Study Of Oral Cp-690,550 As An Induction Therapy In Subjects With Moderate To Severe Ulcerative Colitis.
Status: Enrolling
Updated: 8/20/2015
Clinical Application Laboratories, Inc.
mi
from
San Diego, CA
Click here to add this to my saved trials
A Study To Evaluate Both The Efficacy and Safety Profile of CP-690,550 In Patients With Moderately to Severely Active Ulcerative Colitis
A Multicentre, Randomized, Double-blind, Placebo-controlled, Parallel-group Study Of Oral Cp-690,550 As An Induction Therapy In Subjects With Moderate To Severe Ulcerative Colitis.
Status: Enrolling
Updated:  8/20/2015
San Diego Endoscopy Center
mi
from
San Diego, CA
A Study To Evaluate Both The Efficacy and Safety Profile of CP-690,550 In Patients With Moderately to Severely Active Ulcerative Colitis
A Multicentre, Randomized, Double-blind, Placebo-controlled, Parallel-group Study Of Oral Cp-690,550 As An Induction Therapy In Subjects With Moderate To Severe Ulcerative Colitis.
Status: Enrolling
Updated: 8/20/2015
San Diego Endoscopy Center
mi
from
San Diego, CA
Click here to add this to my saved trials
A Study To Evaluate Both The Efficacy and Safety Profile of CP-690,550 In Patients With Moderately to Severely Active Ulcerative Colitis
A Multicentre, Randomized, Double-blind, Placebo-controlled, Parallel-group Study Of Oral Cp-690,550 As An Induction Therapy In Subjects With Moderate To Severe Ulcerative Colitis.
Status: Enrolling
Updated:  8/20/2015
Medical Center at Mount Zion
mi
from
San Francisco, CA
A Study To Evaluate Both The Efficacy and Safety Profile of CP-690,550 In Patients With Moderately to Severely Active Ulcerative Colitis
A Multicentre, Randomized, Double-blind, Placebo-controlled, Parallel-group Study Of Oral Cp-690,550 As An Induction Therapy In Subjects With Moderate To Severe Ulcerative Colitis.
Status: Enrolling
Updated: 8/20/2015
Medical Center at Mount Zion
mi
from
San Francisco, CA
Click here to add this to my saved trials
A Study To Evaluate Both The Efficacy and Safety Profile of CP-690,550 In Patients With Moderately to Severely Active Ulcerative Colitis
A Multicentre, Randomized, Double-blind, Placebo-controlled, Parallel-group Study Of Oral Cp-690,550 As An Induction Therapy In Subjects With Moderate To Severe Ulcerative Colitis.
Status: Enrolling
Updated:  8/20/2015
UCSF Endoscopy Unit at Mount Zion
mi
from
San Francisco, CA
A Study To Evaluate Both The Efficacy and Safety Profile of CP-690,550 In Patients With Moderately to Severely Active Ulcerative Colitis
A Multicentre, Randomized, Double-blind, Placebo-controlled, Parallel-group Study Of Oral Cp-690,550 As An Induction Therapy In Subjects With Moderate To Severe Ulcerative Colitis.
Status: Enrolling
Updated: 8/20/2015
UCSF Endoscopy Unit at Mount Zion
mi
from
San Francisco, CA
Click here to add this to my saved trials
A Study To Evaluate Both The Efficacy and Safety Profile of CP-690,550 In Patients With Moderately to Severely Active Ulcerative Colitis
A Multicentre, Randomized, Double-blind, Placebo-controlled, Parallel-group Study Of Oral Cp-690,550 As An Induction Therapy In Subjects With Moderate To Severe Ulcerative Colitis.
Status: Enrolling
Updated:  8/20/2015
Los Angeles Biomedical Research Institute at Harbor UCLA Medical Center
mi
from
Torrance, CA
A Study To Evaluate Both The Efficacy and Safety Profile of CP-690,550 In Patients With Moderately to Severely Active Ulcerative Colitis
A Multicentre, Randomized, Double-blind, Placebo-controlled, Parallel-group Study Of Oral Cp-690,550 As An Induction Therapy In Subjects With Moderate To Severe Ulcerative Colitis.
Status: Enrolling
Updated: 8/20/2015
Los Angeles Biomedical Research Institute at Harbor UCLA Medical Center
mi
from
Torrance, CA
Click here to add this to my saved trials
A Study To Evaluate Both The Efficacy and Safety Profile of CP-690,550 In Patients With Moderately to Severely Active Ulcerative Colitis
A Multicentre, Randomized, Double-blind, Placebo-controlled, Parallel-group Study Of Oral Cp-690,550 As An Induction Therapy In Subjects With Moderate To Severe Ulcerative Colitis.
Status: Enrolling
Updated:  8/20/2015
Bristol Hospital
mi
from
Bristol, CT
A Study To Evaluate Both The Efficacy and Safety Profile of CP-690,550 In Patients With Moderately to Severely Active Ulcerative Colitis
A Multicentre, Randomized, Double-blind, Placebo-controlled, Parallel-group Study Of Oral Cp-690,550 As An Induction Therapy In Subjects With Moderate To Severe Ulcerative Colitis.
Status: Enrolling
Updated: 8/20/2015
Bristol Hospital
mi
from
Bristol, CT
Click here to add this to my saved trials